CANQFCanaQuest Medical Corporation

About CanaQuest Medical Corporation (CANQF)

CanaQuest Medical Corporation (CANQF) is a Drug Manufacturers - Specialty & Generic company headquartered in Mississauga, ON, Canada whose shares trade over-the-counter on the Pink tier.

CanaQuest Medical, an award-winning, Clinical Stage/Life-Sciences Company, is focused on drug discovery and development of next-generation targeted therapeutics within the endocannabinoid system utilizing specific brain receptors. The drug candidate targeted for human trials is the result of R&D for cannabidiol formulations plus a drug delivery system maximizing bioavailability. The Company is working with consultants and has mapped out the regulatory pathway for a Drug Identification Number (DIN) for epilepsy, including initiating human trials, with the US - FDA and Health Canada. CanaQuest is the industry partner for research and product development with Dr. Steven Laviolette, a professor, and neuroscientist, at Western University.

Products and services

Research on cannabinoids molecules for the development of products to treat neurological conditions. At present the company is pre-revenue and the products are in the final stages of being ready for an introduction to the market.

CANQF key facts

Ticker symbol

CANQF

Market tier

Pink

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Mississauga, ON, Canada

Country of incorporation

CA

Year of incorporation

2008

Employees

7

Estimated market cap

$256.9K (as of May 9, 2025)

Shares outstanding

21,411,377

Reporting standard

Alternative Reporting Standard

Audit status

Unaudited

Fiscal year end

3/31

Latest filing

Quarterly Report (Dec 31, 2024)

CanaQuest Medical Corporation leadership

• Paul B Ramsay — CEO
• Richard Rusiniak — President
• Ross Eastley — CFO

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Pink stocks · OTC stocks starting with C